Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20988207 | 0.79 | — | — | |
| SCHEMBL22361443 | 0.78 | LMNA (0.31) | — | |
| SCHEMBL1783299 | 0.74 | CA1 (0.46) | CA1CA2 | |
| SCHEMBL23617843 | 0.72 | — | — | |
| SCHEMBL4067728 | 0.72 | CA1 (0.32) | CA1CA2 | |
| SCHEMBL11214230 | 0.72 | CA1 (0.43) | CA1CA2 | |
| SCHEMBL9379342 | 0.71 | CA1 (0.33) | CA1CA2 | |
| SCHEMBL3928974 | 0.70 | CA1 (0.36) | CA1CA2 | |
| SCHEMBL5018108 | 0.69 | — | — | |
| SCHEMBL20988208 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200039960-A1 | RORC2 INHIBITORS AND METHODS OF USE THEREOF | PFIZER INC. (US) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039960-A1 | RORC2 INHIBITORS AND METHODS OF USE THEREOF | RORC, RORB, RORA | CA1 1025/4885CA2 609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.